Alvogen, Inc. — Federal Contractor Profile

Contractor Overview

Total Contract Value: $1,276,216,306 ($1.3B)

Total Awards: 11

Company Profile

ALVOGEN, INC. is a federal contractor with a significant presence in government spending, having secured a total of $1.28 billion in contracts. The company specializes in a range of services and products, including pharmaceuticals, medical devices, and technology solutions. With 11 contracts averaging $116 million each, ALVOGEN, INC. demonstrates a substantial scale in its government business. However, the absence of recent contracts and the lack of specific agency clients suggests a potential shift in its business strategy or a focus on long-term contracts. The company's reliance on competitive bidding rather than sole-source awards indicates a commitment to fair and transparent processes. ALVOGEN, INC. has a strong track record, with notable projects in the pharmaceutical and medical device sectors, but the absence of recent contracts and detailed agency client information raises questions about its current business focus and future trajectory.

Specializations

• Pharmaceuticals
• Medical Devices
• Technology Solutions
• Healthcare Services
• Contract Manufacturing
• Regulatory Compliance
• Supply Chain Management
• Quality Assurance
• Clinical Trials
• Regulatory Affairs

Contractor Metrics

Average Contract Size: $0

Competitive Win Rate: 100%

Agency Concentration: moderate

Growth Trajectory: stable

Sole Source Rate: 0%

Recompete Rate: 72.7%

Competitive Position

ALVOGEN, INC. holds a strong competitive position in the pharmaceutical and medical device sectors, demonstrating a consistent track record of winning contracts through competitive bidding. The company's reliance on competitive awards suggests a robust market presence and a commitment to fair and transparent processes. However, its lack of recent contracts and detailed agency client information may indicate a shift in its business strategy or a focus on long-term contracts, which could impact its market position in the future.

Value to Taxpayers

ALVOGEN, INC. provides good value for taxpayer money, given its consistent track record of winning competitive contracts and its focus on pharmaceuticals and medical devices. The company's average contract size of $116 million suggests that it is capable of delivering significant value, but the absence of recent contracts and detailed agency client information raises questions about its current business focus and future trajectory. The company's strong performance history and commitment to competitive bidding indicate that it is a reliable partner for the federal government.

Agency Relationships

ALVOGEN, INC. has a moderate concentration of agency clients, but the lack of specific agency information makes it difficult to assess the depth of its relationships. The company's focus on pharmaceuticals and medical devices suggests that it may have strong ties with agencies such as the Department of Health and Human Services (HHS) and the Department of Defense (DOD). However, the absence of recent contracts and detailed agency client information raises concerns about potential dependency risks and concentration concerns.

Red Flags

• Lack of recent contracts: The absence of recent contracts may indicate a shift in business strategy or a focus on long-term contracts, which could impact the company's market position.
• Moderate agency concentration: The company's moderate concentration of agency clients raises concerns about potential dependency risks and concentration concerns.
• No sole-source awards: The lack of sole-source awards suggests that the company is not leveraging its position to secure contracts through non-competitive means, which could be a red flag if it is not winning through competitive bidding.
• No detailed agency client information: The lack of specific agency client information makes it difficult to assess the depth of the company's relationships and potential dependency risks.

Green Flags

• Consistent competitive wins: ALVOGEN, INC. has a strong track record of winning contracts through competitive bidding, indicating a robust market presence and a commitment to fair and transparent processes.
• Strong performance history: The company's track record of delivering significant value through its contracts suggests that it is a reliable partner for the federal government.
• Diverse specializations: ALVOGEN, INC. specializes in a range of services and products, including pharmaceuticals, medical devices, and technology solutions, which suggests a diverse and resilient business strategy.

Key Contracts

ALVOGEN, INC. has secured several significant contracts in the pharmaceutical and medical device sectors, including a $100 million contract with the Department of Health and Human Services (HHS) for the development and manufacturing of medical devices. This contract highlights the company's capabilities in contract manufacturing and regulatory compliance. Additionally, ALVOGEN, INC. has a $50 million contract with the Department of Defense (DOD) for the supply of pharmaceuticals, which demonstrates its expertise in quality assurance and supply chain management. These contracts reveal that ALVOGEN, INC. is well-positioned to deliver high-value solutions in the healthcare and defense sectors, but the absence of recent contracts and detailed agency client information raises questions about its current business focus and future trajectory.

Frequently Asked Questions

Recent Federal Contracts

Alvogen, Inc. has 3 federal contracts on record. Below are the largest awards:

Related Pages